129 related articles for article (PubMed ID: 6247651)
21. Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
Corrado ML; Kramer M; Cummings M; Eng RH
Sabouraudia; 1982 Jun; 20(2):109-13. PubMed ID: 6287653
[TBL] [Abstract][Full Text] [Related]
22. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of action of the new antimycotic ketoconazole.
Borgers M; Van den Bossche H; De Brabander M
Am J Med; 1983 Jan; 74(1B):2-8. PubMed ID: 6295147
[TBL] [Abstract][Full Text] [Related]
24. In vitro antifungal activity of sertaconazole.
Drouhet E; Dupont B
Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of ergosterol synthesis in Candida albicans by ketoconazole [proceedings].
Van Den Bossche H; Willemsens G; Cools W; Cornelissen F
Arch Int Physiol Biochim; 1979 Oct; 87(4):849-51. PubMed ID: 93943
[No Abstract] [Full Text] [Related]
26. Degenerative changes in fungi after itraconazole treatment.
Borgers M; Van de Ven MA
Rev Infect Dis; 1987; 9 Suppl 1():S33-42. PubMed ID: 3027844
[TBL] [Abstract][Full Text] [Related]
27. [Combinations of antimycotics].
Viviani MA
G Ital Chemioter; 1984; 31(1-2):1-6. PubMed ID: 6088336
[No Abstract] [Full Text] [Related]
28. The effect of Leptospermum petersonii essential oil on Candida albicans and Aspergillus fumigatus.
Hood JR; Burton DM; Wilkinson JM; Cavanagh HM
Med Mycol; 2010 Nov; 48(7):922-31. PubMed ID: 20446888
[TBL] [Abstract][Full Text] [Related]
29. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.
Van den Bossche H; Willemsens G; Cools W; Cornelissen F; Lauwers WF; van Cutsem JM
Antimicrob Agents Chemother; 1980 Jun; 17(6):922-8. PubMed ID: 6250469
[TBL] [Abstract][Full Text] [Related]
31. In-vitro studies of a new oral azole antimycotic, BAY N 7133.
Yamaguchi H; Hiratani T; Plempel M
J Antimicrob Chemother; 1983 Feb; 11(2):135-49. PubMed ID: 6300015
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of new 1-[2-Azido-2-(2,4-dichlorophenyl)ethyl]-1H/-imidazoles and in vitro evaluation of their antifungal activity.
Chevreuil F; Landreau A; Seraphin D; Larcher G; Bouchara JP; Richomme P
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):617-22. PubMed ID: 18821251
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
[TBL] [Abstract][Full Text] [Related]
34. Studies on antifungal agents. 18. In vitro activity of 5,5-disubstituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methy lisoxazol idines and related compounds.
Mullen GB; DeCory TR; Allen SD; Mitchell JT; St Georgiev V
Chemotherapy; 1988; 34(6):444-7. PubMed ID: 2854041
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections.
Niwano Y; Kuzuhara N; Goto Y; Munechika Y; Kodama H; Kanai K; Yoshida M; Miyazaki T; Yamaguchi H
Int J Antimicrob Agents; 1999 Aug; 12(3):221-8. PubMed ID: 10461840
[TBL] [Abstract][Full Text] [Related]
36. Antifungal activity of coumarins.
Montagner C; de Souza SM; Groposoa C; Delle Monache F; Smânia EF; Smânia A
Z Naturforsch C J Biosci; 2008; 63(1-2):21-8. PubMed ID: 18386483
[TBL] [Abstract][Full Text] [Related]
37. Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
Hargrove TY; Garvey EP; Hoekstra WJ; Yates CM; Wawrzak Z; Rachakonda G; Villalta F; Lepesheva GI
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461309
[TBL] [Abstract][Full Text] [Related]
38. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Högl F; Raab W
Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
[No Abstract] [Full Text] [Related]
39. Syntheses and biological evaluation of novel pseudomycin side-chain analogues. Part 2.
Chen SH; Sun X; Boyer R; Paschal J; Zeckner D; Current W; Zweifel M; Rodriguez M
Bioorg Med Chem Lett; 2000 Sep; 10(18):2107-10. PubMed ID: 10999481
[TBL] [Abstract][Full Text] [Related]
40. A novel assay for fungal ketol-isomerase activity.
Nakata M; O'Rourke R; Wilson S; Chilson K; Selitrennikoff CP
J Antibiot (Tokyo); 2001 Sep; 54(9):737-43. PubMed ID: 11714230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
